Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance Congress

MARINA DEL REY, Calif.: MARINA DEL REY, Calif., Nov. 4, 2021 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that Mina Pastagia, Vice President of Clinical Development, will present...

Click to view original post